Methodology of the VECAT study: Vitamin E intervention in cataract and age-related maculopathy

Ophthalmic Epidemiology

Volumn 6, Issue 3, 1999, Pages 195-208

  Garrett, Sinead K M ^a   McNeil, J J ^a   Silagy, C ^b   Sinclair, M ^a   Thomas, A P ^a   Robman, L D ^b   McCarty, C A ^b   Tikellis, G ^a   Taylor, H R ^b  

^a MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^b Alfred Hospital ^*

Author keywords

Age related maculopathy; Antioxidant; Cataract; Macular degeneration; Randomised controlled trial; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; PLACEBO;

ADULT; ARTICLE; AUSTRALIA; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; MALE; METHODOLOGY; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION;

AGED; AGED, 80 AND OVER; CATARACT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; REFERENCE VALUES; SAFETY; TREATMENT OUTCOME; URBAN POPULATION; VICTORIA; VITAMIN E;

EID: 0032709149     PISSN: 09286586     EISSN: None     Source Type: Journal    
DOI: 10.1076/opep.6.3.195.1500     Document Type: Article

References (48)

1. Eccarius S, Clark JI. Effect of aspirin and vitamin E on phase separation in calf lens homogenate. Ophthalm Res 1987;19(2):65-71.
2. Ross WM, Creighton MO, Inch WR, Trevithick JR. Radiation cataract formation diminished by vitamin E in rat lenses in vitro. Exp Eye Res 1983;36(5):645-53.
3. Stewart-DeHaan PJ, Creighton MO, Sanwal M, Ross WM, Trevithick JR. Effects of vitamin E on cortical cataractogenesis induced by elevated temperature in intact rat lenses in medium 199. Exp Eye Res 1981;32(1):51-60.
4. Linklater HA, Dzialoszynski T, McLeod HL, Sanford SE, Trevithick JR. Modelling cortical cataractogenesis. XI. Vitamin C reduces gamma-crystallin leakage from lenses in diabetic rats. Exp Eye Res 1990;51(3):241-7.
5. Ross WM, Creighton MO, Stewart-DeHaan PJ, Sanwal M, Hirst M, Trevithick JR. Modelling cortical cataractogenesis: 3. In vivo effects of vitamin E on cataractogenesis in diabetic rats. Can J Ophthalmol 1982;17(2):61-6.
6. Varma SD, Beachy NA, Richards RD. Photoperoxidation of lens lipids: prevention by vitamin E. Photochem Photobiol 1982;36(6):623-6.
7. Creighton MO, Trevithick JR. Cortical cataract formation prevented by vitamin E and glutathione. Exp Eye Res 1979;29(6):689-93.
8. Creighton MO, Ross WM, Stewart-DeHaan PJ, Sanwal M, Trevithick JR. Modelling cortical cataractogenesis VII: Effects of vitamin E treatment on galactose-induced cataracts. Exp Eye Res 1985;40(2):213-22.
9. Creighton MO, Sanwal M, Stewart-DeHaan PJ, Trevithick JR. Modeling cortical cataractogenesis. V. Steroid cataracts induced by solumedrol partially prevented by vitamin E in vitro. Exp Eye Res 1983;37(1):65-76.
10. Augusteyn RC. Protein modification in cataract; possible oxidative mechanisms. In: Duncan G, editor. Mechanisms of cataract formation in the human lens. London: Academic Press, 1981.
11. Truscott RJ, Augusteyn RC. Oxidative changes in human lens proteins during senile nuclear cataract formation. Biochim Biophys Acta 1977;492(1):43-52.
12. Varma SD, Srivastava VK, Richards RD. Photoperoxidation in lens and cataract formation: preventive role of superoxide dismutase, catalase and vitamin C. Ophthalm Res 1982;14(3):167-75.
13. Fecondo JV, Augusteyn RC. Superoxide dismutase, catalase and glutathione peroxidase in the human cataractous lens. Exp Eye Res 1983;36(1):15-23.
14. McNamara M, Augusteyn RC. The effects of hydrogen peroxide on lens proteins: a possible model for nuclear cataract. Exp Eye Res 1984;38(1):45-56.
15. Robertson JM, Donner AP, Trevithick JR. Vitamin E intake and risk of cataracts in humans. Ann NY Acad Sci 1989;570:372-82.
16. Knekt P, Heliovaara M, Rissanen A, Aromaa A, Aaran RK. Serum antioxidant vitamins and risk of cataract. Brit Med J 1992;305(6866):1392-4.
17. Robertson JM, Donner AP, Trevithick JR. A possible role for vitamins C and E in cataract prevention. Am J Clin Nutrit 1991;53(1 Suppl):346S-351S.
18. Jacques PF, Hartz SC, Chylack LT, Jr., McGandy RB, Sadowski JA. Nutritional status in persons with and without senile cataract: blood vitamin and mineral levels. Am J Clin Nutrit 1988;48(1):152-8.
19. Taylor A. Role of nutrients in delaying cataracts. Ann NY Acad Sci 1992; 669:111-23; discussion 123-4.
20. Jacques PF, Chylack LT Jr., McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988; 106(3):337-40.
21. Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutrit 1991;53(1 Suppl):352S-355S.
22. Leske MC, Chylack LT Jr., Wu SY. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 1991; 109(2):244-51.
23. Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and cataract extraction in women: a prospective study. Brit Med J 1992;305(6849):335-9.
24. Leske MC, Wu SY, Hyman L, et al. Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study Group. Arch Ophthalmol 1995;113(9):1113-9.
25. Mares-Perlman JA, Klein BE, Klein R, Ritter LL. Relation between lens opacities and vitamin and mineral supplement use. Ophthalmology 1994;101(2):315-25.
26. Rouhiainen P, Rouhiainen H, Salonen JT. Association between low plasma vitamin E concentration and progression of early cortical lens opacities. Am J Epidemiol 1996;144(5):496-500.
27. Tavani A, Negri E, Lavecchia C. Food and nutrient intake and risk of cataract. Ann Epidemiol 1996;6(1):41-6.
28. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Publ Health 1994;84(5):788-92.
29. Vitale S, West S, Hallfrisch J, et al. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 1993;4(3): 195-203.
30. Xue AN, Cai QY, Wang SQ, et al. Antioxidant status in persons with and without senile lens changes. Biomed Environm Sci 1996;9(2-3):144-8.
31. Wong L, Ho SC, Coggon D, et al. Sunlight exposure, antioxidant status, and cataract in Hong Kong fishermen. J Epidemiol Commun Health 1993;47(1):46-9.
32. Tissie G, Flangakis S, Missotten L, et al. Antioxidant activity of plasma from subjects with and without senile cataract. Doc Ophthalmol 1993;83(4):357-61.
33. West S, Vitale S, Hallfrisch J, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol 1994;112(2):222-7.
34. Anonymous. Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group [published errata appear in Arch Ophthalmol 1993;111(9):1228, 1993;111(10):1366 and 1993;111(11):1499]. Arch Ophthalmol 1993;111(1):104-9.
35. Mares-Perlman JA, Brady WE, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 1995;113(12):1518-23.
36. Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol 1993;111(8):1041-9.
37. Taylor HR, West SK, Rosenthal FS, et al. Effect of ultraviolet radiation on cataract formation. New Engl J Med 1988;319(22):1429-33.
38. Livingston PM, Guest CS, Stanislavsky Y, et al. A population-based estimate of cataract prevalence: the Melbourne Visual Impairment Project experience. Devel Ophthalmol 1994;26:1-6.
39. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473-83.
40. Raven JC, Court JH, Raven J. Manual for Raven's Progressive Matrices and Vocabulary Scales. London: H.K. Lewis & Co. Ltd., 1986.
41. Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 1994;112(5):630-8.
42. Livingston PM, Carson CA, Stanislavsky YL, Lee SE, Guest CS, Taylor HR. Methods for a population-based study of eye disease: the Melbourne Visual Impairment Project. Ophthalm Epidemiol 1994;1(3):139-48.
43. Seddon JM, Sahagian CR, Glynn RJ, Sperduto RD, Gragoudas ES. Evaluation of an iris color classification system. The Eye Disorders Case-Control Study Group. Invest Ophthalmol Vis Sci 1990;31(8):1592-8.
44. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Optics 1976;53(11):740-5.
45. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39(5):367-74.
46. Taylor HR, West SK. The clinical grading of lens opacities. Austr NZ J Ophthalmol 1989;17(1):81-6.
47. Bailey IL, Bullimore MA, Raasch TW, Taylor HR. Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci 1991;32(2):422-32.
48. The American Academy of Ophthalmology. Preferred Practice Pattern: Diabetic Retinopathy. San Francisco: American Academy of Ophthalmology, 1989: